IDEAS home Printed from https://ideas.repec.org/a/spr/hecrev/v15y2025i1d10.1186_s13561-025-00639-2.html
   My bibliography  Save this article

Health economic evaluations of diagnostic tests for tuberculosis: a narrative review

Author

Listed:
  • Cemre Arpa

    (Technische Universität Berlin
    Heidelberg University)

  • Ahmed Abd El Wahed

    (Leipzig University)

  • Serap Aydin

    (Technische Universität Berlin)

  • Prakash Ghosh

    (Technische Universität Berlin
    Leipzig University)

  • Dinesh Mondal

    (International Centre for Diarrheal Disease Research Bangladesh (icddr,b))

  • Lydia Nakiyingi

    (Makerere University College of Health Sciences)

  • Julius Boniface Okuni

    (Makerere University)

  • Sophie Schneitler

    (University Clinic Saarland)

  • Manfred Weidmann

    (Midge Medical GmbH)

  • Martin Siegel

    (Technische Universität Berlin
    Heidelberg University)

Abstract

Background Tuberculosis is the leading cause of death from infectious diseases globally. Non-specific symptoms and limitations of existing diagnostics involve challenges for informed policymaking and clinical practice. This paper reviews common practices in reporting the selection and definition of cost and effect parameters, and in reporting the translation of effect parameters into utility and disability weights, in health economic evaluations of TB diagnostic tests. Methods A targeted literature search in PubMed, Cochrane Library, Web of Science, and Google Scholar identified health economic evaluations of diagnosis and population screening strategies for TB. Results We found 28 studies comprising 11 cost-effectiveness and 17 cost-utility analyses. Observed patient data were used in 6 studies, 22 relied solely on model-based evaluations. Variations in prevalence, accuracy, and utility parameters were common, the Consolidated Health Economic Evaluation Reporting Standards terminology for costing was only used in 8 out of 28 studies. Discussion Future studies should state the exact type of TB studied, as it can manifest in multiple organs, remain inactive for long periods of time, and since different diagnostics can perform differently depending on the site involved it may influence test accuracies. Additionally, potential impacts of sequential diagnostics on test accuracy and the cost of inaction should receive more attention. Conclusion Precise terminology and transparent definitions of parameters and methodology in health economics evaluations are necessary to generate evidence that guides policymakers and supports clinical decision-making in the context of TB.

Suggested Citation

  • Cemre Arpa & Ahmed Abd El Wahed & Serap Aydin & Prakash Ghosh & Dinesh Mondal & Lydia Nakiyingi & Julius Boniface Okuni & Sophie Schneitler & Manfred Weidmann & Martin Siegel, 2025. "Health economic evaluations of diagnostic tests for tuberculosis: a narrative review," Health Economics Review, Springer, vol. 15(1), pages 1-12, December.
    • Handle: RePEc:spr:hecrev:v:15:y:2025:i:1:d:10.1186_s13561-025-00639-2
    DOI: 10.1186/s13561-025-00639-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1186/s13561-025-00639-2
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1186/s13561-025-00639-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Afschin Gandjour, 2014. "Capturing Disutility from Waiting Time," PharmacoEconomics, Springer, vol. 32(4), pages 423-424, April.
    2. Zuzana Špacírová & David Epstein & Leticia García-Mochón & Joan Rovira & Antonio Olry de Labry Lima & Jaime Espín, 2021. "Correction to: A general framework for classifying costing methods for economic evaluation of health care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 847-847, July.
    3. Fredrik Salvesen Haukaas & Trude Margrete Arnesen & Brita Askeland Winje & Eline Aas, 2017. "Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(4), pages 405-415, May.
    4. Victoria Brennan & Simon Dixon, 2013. "Incorporating Process Utility into Quality Adjusted Life Years: A Systematic Review of Empirical Studies," PharmacoEconomics, Springer, vol. 31(8), pages 677-691, August.
    5. S. Tan & F. Rutten & B. Ineveld & W. Redekop & L. Hakkaart-van Roijen, 2009. "Comparing methodologies for the cost estimation of hospital services," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 39-45, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Laurent Mériade, 2024. "How to Analyze the Practical Relevance of Costing Methods? The Example of Hospital Cost Accounting in France," Abacus, Accounting Foundation, University of Sydney, vol. 60(4), pages 816-851, December.
    2. Aline Lutz de Araujo & Bruna Stella Zanotto & Ana Paula Beck da Silva Etges & Karen Brasil Ruschel & Taís de Campos Moreira & Felipe Cezar Cabral & Erno Harzheim & Marcelo Rodrigues Gonçalves & Robert, 2024. "Utility index and vision-related quality of life in patients awaiting specialist eye care," PLOS ONE, Public Library of Science, vol. 19(8), pages 1-11, August.
    3. Leticia García-Mochón & Zuzana Špacírová & Jaime Espín, 2022. "Costing methodologies in European economic evaluation guidelines: commonalities and divergences," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 979-991, August.
    4. Xiao Xu & Kimberly A Yonkers & Jennifer P Ruger, 2014. "Costs of a Motivational Enhancement Therapy Coupled with Cognitive Behavioral Therapy versus Brief Advice for Pregnant Substance Users," PLOS ONE, Public Library of Science, vol. 9(4), pages 1-10, April.
    5. Georgina Jones & Victoria Brennan & Richard Jacques & Hilary Wood & Simon Dixon & Stephen Radley, 2018. "Evaluating the impact of a ‘virtual clinic’ on patient experience, personal and provider costs of care in urinary incontinence: A randomised controlled trial," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-16, January.
    6. Raulinajtys-Grzybek, Monika, 2014. "Cost accounting models used for price-setting of health services: An international review," Health Policy, Elsevier, vol. 118(3), pages 341-353.
    7. Zuzana Špacírová & David Epstein & Leticia García-Mochón & Joan Rovira & Antonio Olry de Labry Lima & Jaime Espín, 2021. "Correction to: A general framework for classifying costing methods for economic evaluation of health care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 847-847, July.
    8. Alexander V van Schoonhoven & Judith J Gout-Zwart & Marijke J S de Vries & Antoinette D I van Asselt & Evgeni Dvortsin & Pepijn Vemer & Job F M van Boven & Maarten J Postma, 2019. "Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-22, September.
    9. Zuzana Špacírová & David Epstein & Jaime Espín, 2022. "Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(9), pages 1563-1575, December.
    10. Tina Olsson, 2011. "Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(5), pages 445-453, October.
    11. Vogl, Matthias, 2013. "Improving patient-level costing in the English and the German ‘DRG’ system," Health Policy, Elsevier, vol. 109(3), pages 290-300.
    12. Ghislaine van Mastrigt & Caroline van Heugten & Anne Visser-Meily & Leonarda Bremmers & Silvia Evers, 2022. "Estimating the Burden of Stroke: Two-Year Societal Costs and Generic Health-Related Quality of Life of the Restore4Stroke Cohort," IJERPH, MDPI, vol. 19(17), pages 1-15, September.
    13. Grégoire Mercier & Gérald Naro, 2014. "Costing Hospital Surgery Services: The Method Matters," Post-Print hal-01829947, HAL.
    14. Louis Matza & Sandhya Sapra & John Dillon & Anupama Kalsekar & Evan Davies & Mary Devine & Jessica Jordan & Amanda Landrian & David Feeny, 2015. "Health state utilities associated with attributes of treatments for hepatitis C," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(9), pages 1005-1018, December.
    15. Anne-Gaëlle Corroller & Julia Bonastre, 2023. "Patient-reported measures: how useful in health economics?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(1), pages 1-4, February.
    16. Paul-Simon Pugliesi & Hervé Frick & Stéphanie Guillot & Karine Ferrare & Catherine Renzullo & Alexandre Benoist & Serge Ribes & Guillaume Beltramo & Thomas Maldiney & Romain Schiphorst & Caroline Abdu, 2025. "Cost of Carbon in the Total Cost of a Healthcare Procedure: Example of Micro-Costing Study in a French Setting," Applied Health Economics and Health Policy, Springer, vol. 23(2), pages 265-275, March.
    17. Brahim Bouyahyaoui & Naji Saida & Youssef Hafidi, 2022. "Costs associated with using pharmaceuticals for breast cancer treatment at the Hassan II University Hospital in Fez, Morocco : an ABC method trial [Coût de la consommation des produits pharmaceutiq," Post-Print hal-03993420, HAL.
    18. Olivia Pérol & Barbara Charbotel & Lionel Perrier & Sandrine Bonnand & Elodie Belladame & Virginie Avrillon & Paul Rebattu & Frédéric Gomez & Géraldine Lauridant & Maurice Pérol & Beatrice Fervers, 2018. "Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort," IJERPH, MDPI, vol. 15(1), pages 1-13, January.
    19. Louis S. Matza & L. Clark Paramore & Katie D. Stewart & Hayley Karn & Minesh Jobanputra & Andrew C. Dietz, 2020. "Health state utilities associated with treatment for transfusion-dependent β-thalassemia," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(3), pages 397-407, April.
    20. Paul-Simon Pugliesi & Laurie Marrauld & Catherine Lejeune, 2024. "Cost of Carbon in the Total Cost of Healthcare Procedures: A Methodological Challenge," Applied Health Economics and Health Policy, Springer, vol. 22(5), pages 599-607, September.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:hecrev:v:15:y:2025:i:1:d:10.1186_s13561-025-00639-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/13561 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.